IRIS
PALMA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.098
AS - Asia 6.455
EU - Europa 4.533
SA - Sud America 927
Continente sconosciuto - Info sul continente non disponibili 667
AF - Africa 106
OC - Oceania 10
Totale 39.796
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.594
SG - Singapore 3.563
IT - Italia 1.133
CN - Cina 961
BR - Brasile 746
RU - Federazione Russa 673
DE - Germania 605
HK - Hong Kong 552
VN - Vietnam 418
IE - Irlanda 394
BD - Bangladesh 300
FI - Finlandia 269
FR - Francia 269
GB - Regno Unito 265
SE - Svezia 263
UA - Ucraina 249
CA - Canada 231
JP - Giappone 157
IN - India 125
NL - Olanda 89
PL - Polonia 77
KR - Corea 67
AT - Austria 63
MX - Messico 63
AR - Argentina 62
ID - Indonesia 55
ES - Italia 51
TR - Turchia 43
ZA - Sudafrica 41
CR - Costa Rica 34
EC - Ecuador 29
IQ - Iraq 29
CO - Colombia 28
CZ - Repubblica Ceca 26
TT - Trinidad e Tobago 26
BE - Belgio 25
HN - Honduras 23
NI - Nicaragua 21
GP - Guadalupe 20
GT - Guatemala 20
JM - Giamaica 18
SV - El Salvador 18
VE - Venezuela 17
SA - Arabia Saudita 16
KE - Kenya 14
PK - Pakistan 14
UZ - Uzbekistan 14
IL - Israele 13
KG - Kirghizistan 13
MY - Malesia 13
NP - Nepal 12
PE - Perù 12
PY - Paraguay 12
CL - Cile 11
EG - Egitto 11
IR - Iran 11
PH - Filippine 11
AZ - Azerbaigian 10
PT - Portogallo 10
CH - Svizzera 9
PR - Porto Rico 9
AU - Australia 8
JO - Giordania 8
MA - Marocco 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
GR - Grecia 7
LT - Lituania 7
TN - Tunisia 7
BG - Bulgaria 6
CW - ???statistics.table.value.countryCode.CW??? 6
TH - Thailandia 6
UY - Uruguay 6
DZ - Algeria 5
EU - Europa 5
KZ - Kazakistan 5
LB - Libano 5
RS - Serbia 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
DO - Repubblica Dominicana 4
HU - Ungheria 4
MD - Moldavia 4
PA - Panama 4
AL - Albania 3
DM - Dominica 3
EE - Estonia 3
GA - Gabon 3
GY - Guiana 3
HR - Croazia 3
KW - Kuwait 3
OM - Oman 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BH - Bahrain 2
BS - Bahamas 2
DK - Danimarca 2
GE - Georgia 2
Totale 39.104
Salva come PNG Salva come JPEG
Città #
Wilmington 5.271
Woodbridge 5.221
Houston 4.688
Singapore 1.486
Ashburn 1.219
San Jose 949
Fairfield 804
Chandler 630
Hong Kong 541
Beijing 417
Ann Arbor 414
Council Bluffs 369
Rome 368
Dublin 359
Seattle 325
Santa Clara 287
Cambridge 286
Medford 274
The Dalles 250
New York 248
Los Angeles 228
Jacksonville 194
Helsinki 175
Tokyo 149
Ho Chi Minh City 138
Buffalo 136
Lawrence 123
Lauterbourg 104
Dallas 103
Munich 100
North Bergen 100
Milan 96
Chicago 95
Dearborn 93
São Paulo 83
San Diego 77
Moscow 76
Montreal 74
Denver 72
Hanoi 72
Nuremberg 69
Phoenix 66
London 63
Engelhard 55
Atlanta 52
Frankfurt am Main 52
Brooklyn 47
Orem 45
Toronto 45
Menlo Park 41
Jakarta 38
Pune 36
Warsaw 36
Lappeenranta 35
Salt Lake City 34
Redondo Beach 30
Creede 28
Naples 28
Tampa 28
Norwalk 27
St. George 25
Johannesburg 24
San José 24
Seoul 24
Amsterdam 23
Boston 23
Vienna 23
Brussels 22
Mülheim 22
Stockholm 22
Brno 21
Da Nang 21
Managua 21
Rio de Janeiro 21
San Francisco 21
Chennai 20
Zhengzhou 20
Kraków 19
Miami 19
Boardman 18
Brasília 18
Columbus 18
Mexico City 18
San Salvador 18
Vancouver 18
Verona 18
Haiphong 17
San Mateo 17
Elk Grove Village 16
Guatemala City 16
Redwood City 16
Dong Ket 15
Falls Church 15
Poplar 15
Turin 15
Ankara 14
Mumbai 14
Paris 14
Center 13
Charlotte 13
Totale 28.300
Salva come PNG Salva come JPEG
Nome #
Role of individual's T cell immunome in controlling HIV-1 progression 623
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency 570
A 2-month-old male with pyuria and persistent fever 534
Therapeutic DNA Vaccination of Vertically HIV-Infected Children: Report of the First Pediatric Randomised Trial (PEDVAC) 524
Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child 516
B-Sides Serologic Markers of Immunogenicity in Kidney Transplanted Patients 513
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants 508
Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza 507
HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain 503
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation. 498
An atypical case of multifocal infantile haemangioma in a child after Highly Active Antiretroviral Therapy (HAART) during pregnancy 495
Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency 494
Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation 488
Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults 486
Visceral leishmaniasis revealing chronic granulomatous diseases in a child 485
Transitory hypogammaglobulinemia of infancy in FG syndrome [2] 481
Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases 473
Early Highly Active Antiretroviral Therapy Enhances B-cell Longevity 470
. Early-onset monocyte-B-natural killer-dendritic cells’ deficiency successfully treated with hematopoietic stem cell transaplantation 470
Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays 467
Premature aging of the immune system relates with increased anti-lymphocyte antibodies (ALA) after an immunization in HIV-1 infected and kidney transplanted patients 455
HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children 453
Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment 449
Impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain 448
Early antiretroviral therapy in children perinatally infected with HIV: A unique opportunity to implement immunotherapeutic approaches to prolong viral remission 447
A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency 447
The impact of active HIV-1 replication on the physiological age-related decline of immature-transitional B-cells in HIV-1 infected children. 444
Raising awareness of non-hodgkin lymphoma in HIV-infected adolescents: Report of 2 cases in the HAART era 438
HIV is associated with thrombophilia and high D-dimer in children and adolescents 435
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease 434
B-Sides Serologic Markers of Immunogenicity in Kidney Transplanted Patients: Report From 2012Y2013 Flu Vaccination Experience 431
Successful simplification of protease inhibitor-based HAART with triple nucleoside regimens in children vertically infected with HIV 426
Serratia marcescens Osteomyelitis in a Newborn with Chronic Granulomatous 423
The PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV-infected children 422
How should eosinophilic cystitis be treated in patients with chronic granulomatous disease? 420
The PEDVAC trial: Preliminary data from the first therapeutic DNA vaccination in HIV-infected children 418
Inflammatory bowel disease in chronic granulomatous disease: An emerging problem over a twenty years' experience 414
Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression 412
Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis 406
Paediatric HIV infection in Western Africa: the long way to the standard of care 403
Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions 402
Cellular immune profile of kidney transplant patients developing anti-HLA antibodies during childhood 392
Familial Hemophagocytic Lymphohistiocytosis Type 3 Diagnosed at School Age: A Case Report 380
Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency 372
Perturbation of B cell gene expression persists in HIV-infected children despite effective antiretroviral therapy and predicts H1N1 response 361
Paediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses 350
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 344
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children 343
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019. Erratum in: Front Immunol. 2019 May 31;10:1184. 328
Secondary cytomegalovirus infections: How much do we still not know? Comparison of children with symptomatic congenital cytomegalovirus born to mothers with primary and secondary infection 276
The pediatric gut bacteriome and virome in response to SARS-CoV-2 infection 249
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 246
Faster Initial Viral Decay in Female Children Living with HIV 233
Characterization of T and B cell repertoire diversity in patients with RAG deficiency 229
High dimensional cytokine panels reveal common SARS-CoV-2-related inflammation patterns across different latitudes 229
Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission 225
Pediatric routine vaccinations in the COVID 19 lockdown period: the survey of the Italian Pediatric Society 224
Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers 223
Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children 222
Corrigendum : Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies (Frontiers in Immunology (2019) 10 (316) DOI: 10.3389/fimmu.2019.00316) 217
Next-Generation Sequencing Reveals A JAGN1 Mutation in a Syndromic Child with Intermittent Neutropenia 211
Novel Compound Heterozygous Mutations in IL-7 Receptor α Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment. 210
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 207
Immunotherapy with an HIV-DNA vaccine in children and adults 204
Waning of vaccine-induced immunity to measles in kidney transplanted children 198
null 192
Human Immunodeficiency Virus (HIV)-Antibody repertoire estimates reservoir size and time of antiretroviral therapy initiation in virally suppressed perinatally HIV-infected children 191
Prolonged impairment of immunological memory after Anti-CD20 treatment in pediatric idiopathic nephrotic syndrome 190
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children 190
DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study. 187
Severe parainfluenza pneumonia in a case of transient hypogammalobulinemia of infancy 184
Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy 172
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 170
How to dissect the plasticity of antigen specific immune response: a tissue perspective 170
Early ART-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T and B cell memory 167
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients 160
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups – The CONVERS project, report from a pediatric tertiary hospital 155
High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries 154
Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene 150
Enhancement of neuroblastoma NK-cell-mediated lysis through NF-kB p65 subunit-induced expression of FAS and PVR, the loss of which is associated with poor patient outcome 148
The mission is remission: Hope for controlling HIV replication without ART in early-treated perinatally HIV-infected children 147
Case Report: Two Cases of Pediatric Thrombotic Thrombocytopenic Purpura Treated With Combined Therapy 146
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 144
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial 140
Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience 138
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed? 138
Premature B-cell senescence as a consequence of chronic immune activation: Implications for vaccination of immune compromised individuals 137
Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up 133
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine 132
Epstein–Barr virus-associated smooth muscle tumor in a female with ataxia telangiectasia: a case report 130
Missed opportunities to prevent mother-to-child transmission of HIV in Italy 130
The second generation of HIV-1 vertically exposed infants: A case series from the Italian Register for paediatric HIV infection 129
Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology 126
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference 126
Induction of il21 in peripheral t follicular helper cells is an indicator of influenza vaccine response in a previously vaccinated HIV-infected pediatric cohort 125
The CARMA Study: Early Infant Antiretroviral Therapy - Timing Impacts on Total HIV-1 DNA Quantitation 12 Years Later 124
OMIC Technologies and vaccine development: From the identification of vulnerable individuals to the formulation of invulnerable vaccines 123
Targeted treatment of autoimmune cytopenias in primary immunodeficiencies 122
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 122
Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies 120
Totale 30.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.553
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.286 0 0 0 0 270 109 23 55 228 76 129 396
2022/20231.819 159 149 42 186 134 411 239 117 220 8 99 55
2023/2024901 70 107 39 18 85 231 57 37 24 25 88 120
2024/20255.452 135 927 427 271 116 375 270 265 446 417 1.036 767
2025/20268.079 631 433 825 688 664 326 1.144 963 837 690 521 357
2026/20273.323 506 384 1.246 1.182 5 0 0 0 0 0 0 0
Totale 39.796